Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.63 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7961103 | 0.92 | ITGB3 (0.72) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| SCHEMBL7951737 | 0.92 | ITGB3 (0.72) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| SCHEMBL7951602 | 0.92 | ITGB3 (0.72) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| SCHEMBL7966945 | 0.92 | ITGB3 (0.72) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| SCHEMBL7981895 | 0.91 | ITGB3 (0.66) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL7960021 | 0.91 | ITGB3 (0.71) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| Hydrochloric Acid SCHEMBL7969571 | 0.91 | ITGB3 (0.71) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| Acetic Acid SCHEMBL7963605 | 0.90 | ITGB3 (0.70) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| Maleic Acid SCHEMBL7951564 | 0.89 | ITGB3 (0.69) | ITGB3ITGA2BKMT2AMAPTMEN1 | |
| Fumaric Acid SCHEMBL6135497 | 0.89 | ITGB3 (0.69) | ITGB3ITGA2BKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6191282-B1 | DERIVATIVES OF 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC RING IS USED AS ANTICARCINOGENIC AGENT AND ANTICOAGULANT | HOECHST MARION ROUSSEL (DE) | 2001-02-20 | — | — | US | disclosed |
| US-5981492-A | ADMINISTERED TO THE PATIENT TO INHIBIT THROMBOCYTE AGGREGATION, THE METASTASIZATION OF CARCINOMA CELLS, THE BINDING OF OSTEOCLASTS TO THE BONE SURFACE, OR FOR THE TREATMENT OF THROMBOSES | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-11-09 | — | — | US | disclosed |